Publications by authors named "Aya Ahmed Ali"
Article Synopsis
- * The development of mAbs has evolved from murine antibodies to humanized versions, significantly reducing side effects while offering targeted treatments; however, their high production costs remain a challenge.
- * Innovations like biosimilar antibodies and advancements in antibody engineering are enhancing the effectiveness and affordability of mAbs, potentially transforming drug therapies and addressing unmet medical needs.
